FDA Inspection 1064726 — Aspire Fertility Institute Dallas
The FDA completed an inspection of Aspire Fertility Institute Dallas on Aug 22, 2018 in Addison, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Addison, TX (United States)